Search

Sayan Mondal

from Newark, NJ
Get Report
Connected to:
Alex B Mondal, 37Anita R Mondal, 55Ashish K Mondal, 43Babul C Mondal, 36Goutam Mondal, 40Kishore K Mondal, 52Pravakar Mondal, 52Rajib Mondal, 42Sangeeta Mondal, 32Satyajit Mondal, 50

Sayan Mondal Phones & Addresses

  • Newark, NJ
  • New York, NY
  • Worcester, MA
  • Jersey City, NJ

Resumes

Resumes

Sayan Mondal Photo 1

Sayan Mondal

View page
Location:
New York, NY
Industry:
Computer Software
Work:
Weill Cornell Medical College, Cornell University - New York City since Sep 2010
Graduate Research Assistant
Weill Cornell Medical College, Cornell University Sep 2011 - Dec 2011
Teaching Assistant (in addition to Research Assistant)
Weill Cornell Medical College, Cornell University - New York City Sep 2008 - Aug 2010
Graduate Fellow
Weill Cornell Medical College, Cornell University Feb 2010 - Jun 2010
Teaching Assistant (in addition to fellowship)
Worcester Polytechnic Institute 2007 - 2008
Tutor, Dept. of Academic Advising
Education:
Cornell University 2008 - 2013
PhD, Physiology and Biophysics Worcester Polytechnic Institute 2004 - 2008
Bachelor of Science, Major: Physics, Minor: Math South Point
Skills:
Biophysics
Computational Biology
Molecular Dynamics
Computational Modeling
Bioinformatics
Cell Signaling
Membrane Proteins
Membrane
Physics
Matlab
Mathematical Modeling
Molecular Modeling
Gpcrs
Partial Differential Equations
Finite Element Analysis
Optimizations
Drug Discovery
Transporters
Cholesterol
Atherosclerosis
Interests:
United States Chess Federation
Chess National Master
Sayan Mondal Photo 2

Sayan Mondal

View page
Sayan Mondal Photo 3

Sayan Mondal

View page
Sayan Mondal Photo 4

Sayan Mondal

View page
Sayan Mondal Photo 5

Sayan Mondal

View page

Publications

Us Patents

Tyk2 Inhibitors And Uses Thereof

View page
US Patent:
20220356184, Nov 10, 2022
Filed:
Mar 23, 2021
Appl. No.:
17/210066
Inventors:
- Cambridge MA, US
Jeremy Robert Greenwood - Brooklyn NY, US
Sayan Mondal - New York NY, US
Scott D. Cowen - Cambridge MA, US
Thomas H. McLean - Cambridge MA, US
International Classification:
C07D 487/04
A61P 17/06
A61P 37/02
A61P 11/06
A61P 19/02
A61P 29/00
A61P 35/00
C07D 519/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Substituted Pyrazolo[1,5-A]Pyrimidines As Tyk2 Inhibitors

View page
US Patent:
20230110996, Apr 13, 2023
Filed:
Jun 14, 2022
Appl. No.:
17/806893
Inventors:
- Cambridge MA, US
Jeremy Robert Greenwood - Brooklyn NY, US
Sayan Mondal - New York NY, US
International Classification:
C07D 519/00
C07D 487/04
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

6-Heteroaryloxy Benzimidazoles And Azabenzimidazoles As Jak2 Inhibitors

View page
US Patent:
20230099203, Mar 30, 2023
Filed:
Dec 22, 2021
Appl. No.:
17/559051
Inventors:
- New York NY, US
Jeremy R. Greenwood - Brooklyn NY, US
Sayan Mondal - New York NY, US
Jiayi Xu - Marlboro NJ, US
Phani Ghanakota - Edison NJ, US
Fiona Michelle McRobb - Brooklyn NY, US
Nicholas Boyles - Hillsboro OR, US
International Classification:
C07D 519/00
Abstract:
The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

Cyclic Compounds And Methods Of Using Same

View page
US Patent:
20230101747, Mar 30, 2023
Filed:
Dec 3, 2020
Appl. No.:
17/781559
Inventors:
- New York NY, US
Sayan Mondal - New York NY, US
Phani Ghanakota - Edison NJ, US
Nicholas Boyles - Hillsboro OR, US
Leah Frye - New York NY, US
Jeremy Robert Greenwood - Brooklyn NY, US
Haifeng Tang - Metuchen NJ, US
Adam Marc Levinson - Astoria NY, US
International Classification:
A61K 31/551
A61K 45/06
C07D 495/16
C07D 498/16
C07D 519/00
A61K 31/5383
A61K 31/553
Abstract:
The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.

Tyk2 Inhibitors And Uses Thereof

View page
US Patent:
20230074228, Mar 9, 2023
Filed:
Jul 20, 2022
Appl. No.:
17/813805
Inventors:
- Cambridge MA, US
Jeremy Robert GREENWOOD - Brooklyn NY, US
Donna L. ROMERO - Chesterfield MO, US
Geraldine C. HARRIMAN - Charlestown RI, US
Ronald T. WESTER - Ledyard CT, US
Mee SHELLEY - Tigard OR, US
Joshua Jahmil KENNEDY-SMITH - New York NY, US
Markus DAHLGREN - Stratford CT, US
Sayan MONDAL - New York NY, US
Shaughnessy ROBINSON - Westerly RI, US
International Classification:
C07D 471/04
A61P 37/00
A61P 35/00
C07D 519/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Tyk2 Inhibitors And Uses Thereof

View page
US Patent:
20230056447, Feb 23, 2023
Filed:
Sep 14, 2021
Appl. No.:
17/447648
Inventors:
- Cambridge MA, US
Jeremy Robert Greenwood - Brooklyn NY, US
Sayan Mondal - New York NY, US
Scott D. Cowen - Cambridge MA, US
Thomas H. Mclean - Cambridge MA, US
International Classification:
C07D 487/04
A61P 19/02
A61P 37/02
A61P 29/00
A61P 17/06
C07D 519/00
A61P 11/06
A61P 35/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Tyk2 Inhibitors And Uses Thereof

View page
US Patent:
20210094948, Apr 1, 2021
Filed:
Feb 28, 2020
Appl. No.:
16/804951
Inventors:
- Cambridge MA, US
Silvana Marcel Leit de Moradei - Burlington MA, US
Craig E. Masse - Cambridge MA, US
Thomas H. McLean - Cambridge MA, US
Sayan Mondal - New York NY, US
International Classification:
C07D 471/04
C07D 473/36
C07D 473/32
C07D 473/28
A61P 25/28
A61P 35/02
A61P 5/26
A61P 3/10
A61P 37/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Tyk2 Inhibitors And Uses Thereof

View page
US Patent:
20210047319, Feb 18, 2021
Filed:
Jul 24, 2020
Appl. No.:
16/938522
Inventors:
- Cambridge MA, US
Jeremy Robert GREENWOOD - Brooklyn NY, US
Donna L. ROMERO - Chesterfield MO, US
Geraldine C. HARRIMAN - Charlestown RI, US
Ronald T. WESTER - Ledyard CT, US
Mee SHELLEY - Tigard OR, US
Joshua Jahmil KENNEDY-SMITH - New York NY, US
Markus DAHLGREN - Stratford CT, US
Sayan MONDAL - New York NY, US
Shaughnessy ROBINSON - Westerly RI, US
International Classification:
C07D 471/04
A61P 37/00
A61P 35/00
C07D 519/00
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
Control profile
Sayan Mondal from Newark, NJ Get Report